Completed OBSERVATIONAL NCT00260468

Brain Abnormalities in Late-Onset Major Depression

Structural and Functional Cerebral Findings in Late-Onset Major Depression

Sponsor: Bayer

Interventions Clinical examination program

Updated 10 times since 2017 Last updated: Oct 21, 2009 Started: Nov 30, 2005 Completion: Dec 31, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00260468, this observational or N/A phase trial focuses on Major Depression and remains completed. Sponsored by Bayer, it has been updated 10 times since 2005, reflecting substantial change activity. Mental health research at this phase helps define safety and dosing parameters for future study.

Status Flow

Change History

10 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Dec 2021 — Jul 2024 [monthly]

Completed
Jan 2021 — Dec 2021 [monthly]

Completed
Nov 2020 — Jan 2021 [monthly]

Completed

▶ Show 5 earlier versions

Jun 2018 — Nov 2020 [monthly]

Completed
May 2018 — Jun 2018 [monthly]

Completed
Apr 2018 — May 2018 [monthly]

Completed

Phase: NA → None
Aug 2017 — Apr 2018 [monthly]

Completed NA
Jan 2017 — Aug 2017 [monthly]

Completed NA

First recorded

Nov 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Bayer
The Danish Medical Research Council
University of Aarhus

Data source: University of Aarhus

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Risskov, Denmark